홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

3,5-Heptanedione → 2-[3-(4-Chlorophenoxy)propyl]-5,7-diethyl-[1,2,4]triazolo[1,5-a]pyrimidine

HRID 1752817
인쇄

반응식

HRID 1752817 반응식
[Cl:1][C:2]1[CH:17]=[CH:16][C:5]([O:6][CH2:7][CH2:8][CH2:9][C:10]2[N:14]=[C:13]([NH2:15])[NH:12][N:11]=2)=[CH:4][CH:3]=1.[CH3:18][CH2:19][C:20](=O)[CH2:21][C:22](=O)[CH2:23][CH3:24]>>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([O:6][CH2:7][CH2:8][CH2:9][C:10]2[N:14]=[C:13]3[N:15]=[C:20]([CH2:19][CH3:18])[CH:21]=[C:22]([CH2:23][CH3:24])[N:12]3[N:11]=2)=[CH:16][CH:17]=1
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 819233,5-HeptanedioneHCID 178508402HCID 178508402, 화합물

생성물 1

HCID 766846872-[3-(4-Chlorophenoxy)propyl]-5,7-diethyl-[1,2,4]triazolo[1,5-a]pyrimidine수율 44%

실험 절차

The title compound was prepared according to the experimentals described for Example 22 above from 3-[3-(4-chlorophenoxy)propyl]-1H-1,2,4-triazol-5-amine and 3,5-heptanedione in 44% yield; 1H NMR (DMSO-d6, 400 MHz) δ ppm: 7.31 (dd, 1H), 7.29 (dd, 1H), 7.11 (s, 1H), 6.96 (dd, 1H), 6.94 (dd, 1H), 4.08 (t, 2H), 3.07 (q, 2H), 2.97 (t, 2H), 2.86 (q, 2H), 2.20 (m, 2H), 1.33 (t, 3H), 1.27 (t, 3H).

출처 및 근거

ORD 기록
ord-05c243ae70324d5ebc86776090fa9e8d
출처 데이터셋
uspto-grants-2015_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09163027B2

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트